CLINICAL_TRIALS
trial_result
· 2014-07-24
Clinical Trial Update: Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism [Phase 3]
Summary
Phase 3 safety study of enclomiphene citrate in men with secondary hypogonadism has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2014-07-24